Gabelli Funds’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Gabelli Funds's EW Position: Q3 2023 in Review
Gabelli Funds sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 166,455 shares — an estimated $15.7M sold.
Gabelli Funds first reported a position in EW in Q1 2018 and held it in 19 quarters. The position peaked at $39.8M in Q4 2021. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.
- Gabelli Funds reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
- Gabelli Funds sold 166,455 Edwards Lifesciences shares in Q3 2023, an estimated $15.7M.
- Gabelli Funds first reported a position in Edwards Lifesciences in Q1 2018 and held it in 19 quarters.
- Gabelli Funds's Edwards Lifesciences position peaked at $39.8M in Q4 2021.
- 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.
Based on Gabelli Funds's 13F filing for Q3 2023, filed 8 Nov 2023.